Literature DB >> 18554309

Trends of mortality and causes of death among HIV-infected patients in Taiwan, 1984-2005.

C-H Yang1, Y-F Huang, C-F Hsiao, Y-L Yeh, H-R Liou, C-C Hung, S-Y Yang.   

Abstract

BACKGROUND: The aim of this study was to analyse the trends of mortality and causes of death among HIV-infected patients in Taiwan from 1984 to 2005.
METHODS: Registered data and death certificates for HIV-infected patients from Taiwan Centers for Disease Control were reviewed. Mortality rate and causes of deaths were compared among patients whose HIV diagnosis was made in three different study periods: before the introduction of highly active antiretroviral therapy (HAART) (pre-HAART: from 1 January 1984 to 31 March 1997), in the early HAART period (from 1 April 1997 to 31 December 2001), and in the late HAART period (from 1 January 2002 to 31 December 2005). A subgroup of 1161 HIV-infected patients (11.4%) followed at a university hospital were analysed to investigate the trends of and risk factors for mortality.
RESULTS: For 10 162 HIV-infected patients with a mean follow-up of 1.97 years, the mortality rate of HIV-infected patients declined from 10.2 deaths per 100 person-years (PY) in the pre-HAART period to 6.5 deaths and 3.7 deaths per 100 PY in the early and late HAART periods, respectively (P<0.0001). For the 1161 patients followed at a university hospital (66.8% with CD4 count <200 cells/microL), HAART reduced mortality by 89% in multivariate analysis, and the adjusted hazard ratio for death was 0.28 (95% confidence interval 0.24, 0.33) in patients enrolled in the late HAART period compared with those in the pre-HAART period. Seventy-six per cent of the deaths in the pre-HAART period were attributable to AIDS-defining conditions, compared with 36% in the late HAART period (P<0.0001). The leading causes of non-AIDS-related deaths were sepsis (14.7%) and accidental death (8.3%), both of which increased significantly throughout the three study periods. Compared with patients acquiring HIV infection through sexual contact, injecting drug users were more likely to die from non-AIDS-related causes.
CONCLUSIONS: The mortality of HIV-infected patients declined significantly after the introduction of HAART in Taiwan. In the HAART era, AIDS-related deaths decreased significantly while deaths from non-AIDS-related conditions increased.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18554309     DOI: 10.1111/j.1468-1293.2008.00600.x

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  26 in total

1.  Regional Differences in the Prevalence of Major Opportunistic Infections among Antiretroviral-Naïve Human Immunodeficiency Virus Patients in Japan, Northern Thailand, Northern Vietnam, and the Philippines.

Authors:  Louie Mar A Gangcuangco; Ikumi Sawada; Naho Tsuchiya; Cuong D Do; Thanh Thuy T Pham; Archawin Rojanawiwat; Marissa Alejandria; Katerina Leyritana; Yoshiyuki Yokomaku; Panita Pathipvanich; Koya Ariyoshi
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345

2.  An observational case series of HIV-positive patients treated with open reduction internal fixation for a closed lower extremity fracture.

Authors:  Jiandong Hao; Benoit Herbert; Juan C Quispe; Derly O Cuellar; Vivek Chadayammuri; Ji Wan Kim; Heather Young; Mark E Hake; Mark E Hammerberg; David J Hak; Cyril Mauffrey
Journal:  Eur J Orthop Surg Traumatol       Date:  2015-02-04

3.  Glycemic control in HIV-infected patients with diabetes mellitus and rates of meeting American Diabetes Association management guidelines.

Authors:  Michael J Satlin; Donald R Hoover; Marshall J Glesby
Journal:  AIDS Patient Care STDS       Date:  2011-01       Impact factor: 5.078

4.  Sex stratification of the trends and risk of mortality among individuals living with HIV under different transmission categories.

Authors:  Chun-Yuan Lee; Yi-Pei Lin; Hung-Pin Tu; Sheng-Fan Wang; Po-Liang Lu
Journal:  Sci Rep       Date:  2022-06-03       Impact factor: 4.996

5.  Causes of Death in Hospitalized HIV Patients in the Early Anti-Retroviral Therapy Era.

Authors:  M Lartey; A Asante-Quashie; A Essel; E Kenu; V Ganu; A Neequaye
Journal:  Ghana Med J       Date:  2015-03

Review 6.  HIV treatment as prevention: natural experiments highlight limits of antiretroviral treatment as HIV prevention.

Authors:  David P Wilson
Journal:  PLoS Med       Date:  2012-07-10       Impact factor: 11.069

7.  Mortality in HIV infected individuals in Pune, India.

Authors:  Manisha Ghate; Swapna Deshpande; Srikanth Tripathy; Sheela Godbole; Madhura Nene; Madhuri Thakar; Arun Risbud; Robert Bollinger; Sanjay Mehendale
Journal:  Indian J Med Res       Date:  2011-04       Impact factor: 2.375

8.  Slow immunological progression in HIV-1 CRF07_BC-infected injecting drug users.

Authors:  Pi-Han Lin; Chung-Chih Lai; Jia-Ling Yang; Hui-Lin Huang; Ming-Siang Huang; Mao-Song Tsai; Chia-Jui Yang; Chien-Ling Cheng; Yi-Ching Su; Shu-Fang Chang; Wen-Chun Liu; Chien-Ching Hung; Sui-Yuan Chang; Shan-Chwen Chang
Journal:  Emerg Microbes Infect       Date:  2013-12-11       Impact factor: 7.163

9.  Mycobacterial bone marrow infections at a medical centre in Taiwan, 2001-2009.

Authors:  S-H Lin; C-C Lai; S-H Huang; C-C Hung; P-R Hsueh
Journal:  Epidemiol Infect       Date:  2013-10-29       Impact factor: 4.434

10.  Continuous increase of cardiovascular diseases, diabetes, and non-HIV related cancers as causes of death in HIV-infected individuals in Brazil: an analysis of nationwide data.

Authors:  Adelzon A Paula; Mauro Schechter; Suely H Tuboi; José Claudio Faulhaber; Paula M Luz; Valdiléa G Veloso; Ronaldo I Moreira; Beatriz Grinsztejn; Lee H Harrison; Antonio G Pacheco
Journal:  PLoS One       Date:  2014-04-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.